-
If you purchased shares of Entellus Medical Inc (NASDAQ:ENTL) and currently hold any of those NASDAQ:ENTL shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
An investigation on behalf of investors, who currently hold shares of Entellus Medical Inc (NASDAQ:ENTL), was announced concerning whether the takeover of Entellus Medical Inc. by Stryker Corporation is unfair to NASDAQ:ENTL stockholders.
The investigation by a law firm concerns whether certain officers and directors of Entellus Medical Inc breached their fiduciary duties owed to NASDAQ:ENTL investors in connection with the proposed acquisition.
On December 7, 2017, Entellus Medical Inc (NASDAQ:ENTL) announced a merger agreement by which Stryker Corporation (NYSE:SYK) will acquire Entellus Medical Inc in an all cash transaction for $24.00 per share, or an equity value of approximately $662 million.
However, the investigation concerns whether the offer is unfair to Entellus Medical Inc (NASDAQ:ENTL stockholders. More specifically, the investigation concerns whether the Entellus Medical Inc (NASDAQ:ENTL Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
